| 1 | Consumer Staples | XLP | +3.8% |
| 2 | Utilities | XLU | +1.6% |
| 3 | Real Estate | XLRE | +1.0% |
| 4 | Healthcare | XLV | -1.0% |
| 5 | Financials | XLF | -2.6% |
| 6 | Consumer Disc. | XLY | -2.7% |
| 7 | Materials | XLB | -5.8% |
| 8 | Industrials | XLI | -7.1% |
| 9 | Communication | XLC | -8.2% |
| 10 | Energy | XLE | -11.2% |
| 11 | Technology | XLK | -21.0% |
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. …
| Quarter | Date | EPS est. | Actual | Surprise | YoY | Rev. est. | Actual | Surprise | YoY | Copy |
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 '26 | 11/5/267:01 AM | -$0.09 | -$0.05GAAP | +44.4% | ⚠ Check | $116.0M | $121.5M | +4.7% | +80% | |
| Q2 '26 | 8/6/267:01 AM | -$0.14 | -$0.11GAAP | +21.4% | +67% | $87.6M | $99.3M | +13.4% | +66% | |
| Q1 '26 | 5/7/268:00 AM | -$0.16 | -$0.19GAAP | -18.8% | +47% | $76.0M | $71.4M | -6.0% | +45% | |
| Q4 '25 | 2/24/268:00 AM | -$0.19 | -$0.18GAAP | +5.3% | +31% | $78.6M | $86.8M | +10.3% | +18% | |
| Q3 '25 | 11/6/258:00 AM | -$0.27 | -$0.25GAAP | +7.4% | +11% | $71.8M | $67.5M | -6.1% | +15% | |
| Q2 '25 | 8/7/254:01 PM | -$0.28 | -$0.33GAAP | -17.9% | +3% | $66.8M | $60.0M | -10.3% | +93% | |
| Q1 '25 | 5/8/254:01 PM | -$0.24 | -$0.36GAAP | -50.0% | +14% | $81.5M | $49.3M | -39.5% | ⚠ Check |
⚠ Potential error in calculation, check manually. The two EPS figures may be on different share counts (a stock split one source has not adjusted for). The two revenue figures may be in different units or currencies.
GAAP = diluted EPS as filed with the SEC.